Induction of Malignant Plasma Cell Proliferation by Eosinophils

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Wong, Tina W ^a   Kita, Hirohito ^b   Hanson, Curtis A ^b   Walters, Denise K ^a   Arendt, Bonnie K ^a   Jelinek, Diane F ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; INTERLEUKIN 6;

ARTICLE; BONE MARROW; CELL ACTIVITY; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE MICROPARTICLE; MULTIPLE MYELOMA; PLASMA CELL; STROMA CELL;

BONE MARROW CELLS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; EOSINOPHILS; HUMANS; INTERLEUKIN-6; MULTIPLE MYELOMA; PLASMA CELLS; SOLUBILITY; STROMAL CELLS; SYNDECAN-1;

EID: 84880686635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070554     Document Type: Article

References (40)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA: a cancer journal for clinicians 62: 10-29.
2. Palumbo A, Anderson K, (2011) Multiple myeloma. The New England journal of medicine 364: 1046-1060.
3. Eshaghian S, Berenson JR, (2012) Multiple myeloma: improved outcomes with new therapeutic approaches. Current opinion in supportive and palliative care 6: 330-336.
4. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, et al. (2008) Improved survival in multiple myeloma and the impact of novel therapies. Blood 111: 2516-2520.
5. Noll JE, Williams SA, Purton LE, Zannettino AC, (2012) Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche? Blood cancer journal 2: e91.
6. Manier S, Sacco A, Leleu X, Ghobrial IM, Roccaro AM, (2012) Bone marrow microenvironment in multiple myeloma progression. Journal of biomedicine & biotechnology 2012: 157496.
7. Pellegrino A, Ria R, Di Pietro G, Cirulli T, Surico G, et al. (2005) Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells. British journal of haematology 129: 248-256.
8. Belnoue E, Pihlgren M, McGaha TL, Tougne C, Rochat AF, et al. (2008) APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111: 2755-2764.
9. Tangye SG, (2011) Staying alive: regulation of plasma cell survival. Trends in immunology 32: 595-602.
10. Rodriguez Gomez M, Talke Y, Goebel N, Hermann F, Reich B, et al. (2010) Basophils support the survival of plasma cells in mice. Journal of immunology 185: 7180-7185.
11. Denzel A, Maus UA, Rodriguez Gomez M, Moll C, Niedermeier M, et al. (2008) Basophils enhance immunological memory responses. Nature immunology 9: 733-742.
12. Winter O, Moser K, Mohr E, Zotos D, Kaminski H, et al. (2010) Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 116: 1867-1875.
13. Chu VT, Frohlich A, Steinhauser G, Scheel T, Roch T, et al. (2011) Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nature immunology 12: 151-159.
14. Kim J, Denu RA, Dollar BA, Escalante LE, Kuether JP, et al. (2012) Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells. British journal of haematology 158: 336-346.
15. Kukreja A, Hutchinson A, Dhodapkar K, Mazumder A, Vesole D, et al. (2006) Enhancement of clonogenicity of human multiple myeloma by dendritic cells. The Journal of experimental medicine 203: 1859-1865.
16. Chu VT, Berek C, (2012) Immunization induces activation of bone marrow eosinophils required for plasma cell survival. European journal of immunology 42: 130-137.
17. Jelinek DF, Ahmann GJ, Greipp PR, Jalal SM, Westendorf JJ, et al. (1993) Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications. Cancer research 53: 5320-5327.
18. Arendt BK, Ramirez-Alvarado M, Sikkink LA, Keats JJ, Ahmann GJ, et al. (2008) Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2. Blood 112: 1931-1941.
19. Westendorf JJ, Ahmann GJ, Greipp PR, Witzig TE, Lust JA, et al. (1996) Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK 10: 866-876.
20. Wong TW, Jelinek DF, (2013) Purification of functional eosinophils from human bone marrow. Journal of immunological methods 387: 130-139.
21. Anderson KC, Jones RM, Morimoto C, Leavitt P, Barut BA, (1989) Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73: 1915-1924.
22. Winter O, Mohr E, Manz RA, (2011) Alternative cell types form a Multi-Component-Plasma-Cell-Niche. Immunology letters 141: 145-146.
23. Roccaro AM, Sacco A, Azab AK, Tai Y, Maiso P, et al. (2011) Stroma-Derived Exosomes Mediate Oncogenesis in Multiple Myeloma. Blood 118: ASH Annual Meeting Abstracts.
24. Rothenberg ME, Hogan SP, (2006) The eosinophil. Annual review of immunology 24: 147-174.
25. Chu VT, Beller A, Nguyen TT, Steinhauser G, Berek C, (2011) The long-term survival of plasma cells. Scandinavian journal of immunology 73: 508-511.
26. Nair JR, Rozanski CH, Lee KP, (2012) Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cells. Oncoimmunology 1: 388-389.
27. Benson MJ, Dillon SR, Castigli E, Geha RS, Xu S, et al. (2008) Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. Journal of immunology 180: 3655-3659.
28. Minges Wols HA, Underhill GH, Kansas GS, Witte PL, (2002) The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. Journal of immunology 169: 4213-4221.
29. Greipp PR, Witzig TE, Gonchoroff NJ, Habermann TM, Katzmann JA, et al. (1987) Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies. Mayo Clinic proceedings Mayo Clinic 62: 969-977.
30. Lokhorst HM, Boom SE, Bast BJ, Ballieux RE, (1986) Determination of the plasma cell labelling index with bromodeoxyuridine in a double fluorescence technique. British journal of haematology 64: 271-275.
31. Steensma DP, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, et al. (2001) A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death. Blood 97: 2522-2523.
32. Greipp PR, Lust JA, O'Fallon WM, Katzmann JA, Witzig TE, et al. (1993) Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood 81: 3382-3387.
33. Taube T, Beneton MN, McCloskey EV, Rogers S, Greaves M, et al. (1992) Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. European journal of haematology 49: 192-198.
34. Giuliani N, Rizzoli V, (2007) Myeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myeloma. Leukemia & lymphoma 48: 2323-2329.
35. He J, Liu Z, Zheng Y, Qian J, Li H, et al. (2012) p38 MAPK in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction. Cancer research 72: 6393-6402.
36. Lee JW, Chung HY, Ehrlich LA, Jelinek DF, Callander NS, et al. (2004) IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood 103: 2308-2315.
37. Ehrlich LA, Chung HY, Ghobrial I, Choi SJ, Morandi F, et al. (2005) IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. Blood 106: 1407-1414.
38. Lotfi R, Lee JJ, Lotze MT, (2007) Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. Journal of immunotherapy 30: 16-28.
39. Roufosse F, Garaud S, de Leval L, (2012) Lymphoproliferative disorders associated with hypereosinophilia. Seminars in hematology 49: 138-148.
40. Glantz L, Rintels P, Samoszuk M, Medeiros LJ, (1995) Plasma cell myeloma associated with eosinophilia. American journal of clinical pathology 103: 583-587.